Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with CELG as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|9.96%||Market Vectors Biotech ETF (BBH)||+10.62 (8.21%)|
|7.4%||iShares Nasdaq Biotechnology Index Fund (IBB)||+41.10 (12.04%)|
|4.86%||PowerShares Dynamic Pharmaceuticals (PJP)||+6.26 (8.30%)|
|4.16%||Columbia Select Large Cap Growth ETF (RWG)||+2.52 (5.41%)|
|3.42%||SPDR Select Sector Fund - Health Care (XLV)||+5.54 (7.80%)|
Company Description (as filed with the SEC)
Celgene Corporation, together with its subsidiaries (collectively "we," "our," "us," "Celgene" or the "Company"), is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. We are dedicated to innovative research and development designed to bring new therapies to market and we are involved in research in several scientific areas designed to deliver proprietary next-generation therapies, targeting areas including intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies. Celgene Corporation was incorporated in the State of Delaware in 1986. ... More ...
Where does CELG fit in the risk graph?
|Annual EPS Est:||$3.36|
|Quarterly EPS Est:||1.01|